Back to Search Start Over

Mapping genetic determinants of 184 circulating proteins in 26,494 individuals to connect proteins and diseases

Authors :
Erin Macdonald-Dunlop
Lucija Klarić
Lasse Folkersen
Paul R.H.J. Timmers
Stefan Gustafsson
Jing Hua Zhao
Niclas Eriksson
Anne Richmond
Stefan Enroth
Niklas Mattsson-Carlgren
Daria V. Zhernakova
Anette Kalnapenkis
Martin Magnusson
Eleanor Wheeler
Shih-Jen Hwang
Yan Chen
Andrew P Morris
Bram Prins
Urmo Võsa
Nicholas J. Wareham
John Danesh
Johan Sundstrom
Bruna Gigante
Damiano Baldassarre
Rona J. Strawbridge
Harry Campbell
Ulf Gyllensten
Chen Yao
Daniela Zanetti
Themistocles L. Assimes
Per Eriksson
Daniel Levy
Claudia Langenberg
J. Gustav Smith
Tõnu Esko
Jingyuan Fu
Oskar Hansson
Åsa Johansson
Caroline Hayward
Lars Wallentin
Agneta Siegbahn
Lars Lind
Adam S. Butterworth
Karl Michaëlsson
James E. Peters
Anders Mälarstig
Peter K. Joshi
James F. Wilson
Publication Year :
2021
Publisher :
Cold Spring Harbor Laboratory, 2021.

Abstract

We performed the largest genome-wide meta-analysis (GWAMA) (Max N=26,494) of the levels of 184 cardiovascular-related plasma protein levels to date and reported 592 independent loci (pQTL) associated with the level of at least one protein (1308 significant associations, median 6 per protein). We estimated that only between 8-37% of testable pQTL overlap with established expression quantitative trait loci (eQTL) using multiple methods, while 132 out of 1064 lead variants show evidence for transcription factor binding, and found that 75% of our pQTL are known DNA methylation QTL. We highlight the variation in genetic architecture between proteins and that proteins share genetic architecture with cardiometabolic complex traits. Using cis-instrument Mendelian randomisation (MR), we infer causal relationships for 11 proteins, recapitulating the previously reported relationship between PCSK9 and LDL cholesterol, replicating previous pQTL MR findings and discovering 16 causal relationships between protein levels and disease. Our MR results highlight IL2-RA as a candidate for drug repurposing for Crohn’s Disease as well as 2 novel therapeutic targets: IL-27 (Crohn’s disease) and TNFRSF14 (Inflammatory bowel disease, Multiple sclerosis and Ulcerative colitis). We have demonstrated the discoveries possible using our pQTL and highlight the potential of this work as a resource for genetic epidemiology.

Details

Database :
OpenAIRE
Accession number :
edsair.doi...........ca1fedae227867b04bd6a157e024b7f1